Red X iconGreen tick iconYellow tick icon
The University of Otago has launched a new brand. Find out more

Contact Details

Phone
+64 3 479 7868
Email
augustine.chen@otago.ac.nz
Position
Senior Research Fellow
Department
Department of Biochemistry
Qualifications
PhD
Research summary
Biomedical research, cancer biology, diagnostic test development, biomarker discovery
Memberships
Centre for Translational Cancer Research
Genetics Otago
Maurice Wilkins Centre

Research

My current research focus involves the co-development of a transformative diagnostic test using Next-Generation Sequencing (NGS) with applications in medical, agriculture and environmental sensing sectors. This innovation has attracted pre-seed funding to undertake proof-of-concept experiments towards multimodal signal detection (genetic and epigenetic changes) in circulating tumour DNA. Through minor modification, this test could also be expanded to include other sample types in non-medical sectors and I am currently pursuing collaborations towards such applications.

My speciality has always centred around developing, using or combining existing and emerging methodologies to answer a variety of research questions. This included technical expertise utilising Next Generation Sequencing, high-throughput imaging and drug screening assays, siRNA and miRNA delivery, mouse necropsy as well as standard molecular biology and cell culture techniques.

To date, I have undertaken a range of biomedical research, investigating various aspects of gene regulation in human diseases such as cancer and virus infection (HBV, HPV and norovirus). Such approaches have enabled the identification of disease states and targetable vulnerabilities and has led to the discovery of putative therapeutic drugs (which led to a provisional patent filing) and the development of a diagnostic test for a NZ company (which attracted joint funding from the Ministry of Science and Innovation Technology Transfer Voucher Scheme).

Additional details

Dr Augustine Chen, Centre for Translational Research - Te Aho Matatū.

Publications

Hannah, S. J., Chen, A., Day, R. C., & Black, M. A. (2022). Improvising read accuracy for ctDNA diagnostics. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go Conference Contribution - Published proceedings: Abstract

Clarke, R. M., Hess, A., Caulton, A., Brauning, R., McRae, K., Chen, A., & Clarke, S. (2022, August). Simultaneous investigation of genomic regions of interest: The use of adaptive sampling. Poster session presented at the Applied Genetics/Genomics in Breeding Technologies Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand. Conference Contribution - Poster Presentation (not in published proceedings)

Bhandari, B. K., Lim, C. S., Remus, D. M., Chen, A., van Dolleweerd, C., & Gardner, P. P. (2021). Analysis of 11,430 recombinant protein production experiments reveals that protein yield is tunable by synonymous codon changes of translation initiation sites. PLoS Computational Biology, 17(10), e1009461. doi: 10.1371/journal.pcbi.1009461 Journal - Research Article

Bougen-Zhukov, N., Nouri, Y., Godwin, T., Taylor, M., Hakkaart, C., Single, A., Brew, T., Permina, E., Chen, A., Black, M. A., & Guilford, P. (2019). Allosteric AKT inhibitors target synthetic lethal vulnerabilities in E-cadherin-deficient cells. Cancers, 11(9), 1359. doi: 10.3390/cancers11091359 Journal - Research Article

Beetham, H., Chen, A., Telford, B. J., Single, A., Jarman, K. E., Lackovic, K., … Guilford, P. (2019). A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells. Scientific Reports, 9, 12511. doi: 10.1038/s41598-019-48929-0 Journal - Research Article

Back to top